Dr. Nathan Yozwiak
Nathan Yozwiak, Ph.D
Department of Organismic and Evolutionary Biology
Northwest Building, Room 471
52 Oxford Street
Cambridge, MA 02138
Nathan is a Project Manager in the Sabeti Lab at Harvard University and the Broad Institute. He works toward the establishment of the African Center of Excellence for Genomics of Infectious Disease and completion of the Lassa Fever Populations Genetics project.
He collaborates with researchers and program officers to integrate the business aspects of contract administration and study design and execution. Nathan’s work involves developing genomic diagnostic pipelines, overseeing completion of project milestones, implementing site infrastructure improvements, and serving as a point of contact between all collaborative parties in the U.S. and West Africa.
Nathan received his Ph.D. in Infectious Diseases and Immunity from the University of California, Berkeley, where he studied detection and discovery of known and novel viruses in acute pediatric illness in Nicaragua using viral microarrays and deep sequencing technology. Prior to joining the Sabeti Lab, he was a Hellman Fellow in Science and Technology Policy at the American Academy of Arts and Sciences, where he developed an initiative investigating public trust in childhood vaccines.
- Virus identification in unknown tropical febrile illness cases using deep sequencing
Yozwiak NL, Skewes-Cox P, Stenglein MD, Balmaseda A, Harris E, DeRisi J.
PLoS Negl Trop Dis. (2012).
- Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua
Yozwiak NL, Skewes-Cox P, Gordon A, Saborio S, Kuan G, Balmaseda A, Ganem D, Harris E, DeRisi J.
J Virol. (2010).
- Ask a Scientist: How Did Viruses Evolve from a Universal Common Ancestor?
Howard Hughes Medical Institute Bulletin (2011) May; 45.
- Advancing Research in Science and Engineering II (ARISE II): Unleashing America’s Innovation and Research Enterprise.
American Academy of Arts and Sciences (2013).